HOOK — Hookipa Pharma Income Statement
0.000.00%
Last trade - 00:00
- $77.39m
- -$14.22m
- $20.13m
- 35
- 50
- 86
- 58
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11.9 | 19.6 | 18.4 | 14.2 | 20.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 63 | 72.9 | 100 | 87.4 | 118 |
Operating Profit | -51.1 | -53.3 | -81.7 | -73.2 | -97.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -43 | -44.1 | -75.7 | -64.7 | -81.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -43 | -44.1 | -75.7 | -64.9 | -81.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -43 | -44.1 | -75.7 | -64.9 | -81.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -43 | -44.1 | -75.7 | -64.9 | -81.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -16.8 | -16.9 | -23 | -9.91 | -7.75 |